PetMed Express, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by PetMed Express, Inc. (NASDAQ: PETS) on September 11, 2024. The filing primarily addresses the appointment of a new Chief Financial Officer and the terms of her employment agreement.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and corporate governance changes.
Material Changes
The material change reported is the appointment of Robyn D'Elia as Chief Financial Officer (CFO) and Principal Financial Officer, effective September 16, 2024. Ms. D'Elia brings over 25 years of financial leadership experience, including previous roles as CFO at Odeko and Bed Bath & Beyond.
Compensation and Employment Terms
- Base Salary: $425,000 annually.
- Annual Bonus: Target of 75% of base salary, with a maximum of 150%.
- Initial Equity Grant: Restricted Stock Units (RSUs) valued at $1,000,000, vesting in one-third increments over three years.
- Future Annual Equity: RSUs valued at $240,000 and Performance Stock Units (PSUs) valued at $360,000.
- Severance: In the event of termination without Cause or resignation for Good Reason, Ms. D'Elia is entitled to 12 months of base salary continuation and COBRA reimbursement. In the event of a Change of Control followed by such termination, unvested RSUs would accelerate.
Risks and Forward-Looking Statements
The filing includes standard forward-looking statements regarding the expectations of the new CFO's impact. It directs investors to the "Risk Factors" section of the Company's Form 10-K for the year ended March 31, 2024, for a comprehensive list of risks and uncertainties.
Investor Verification Checklist
- Verify the exact number of RSUs granted based on the "Reference Price" (higher of closing price on grant date or $4.00) once the grant is finalized.
- Review the full text of the Executive Employment Agreement (Exhibit 10.1) for specific definitions of "Cause" and "Good Reason."
- Monitor the Company's Form 10-K for the fiscal year ended March 31, 2024, to understand the broader risk factors affecting the business.
- Confirm the effective date of the CFO transition (September 16, 2024) and any interim financial reporting implications.